Close

Form SC 13D/A Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P. Mar 11, 2021 06:03AM
TRACON Pharmaceuticals Announces Closing of Previously Announced Private Placement and Appointment of Ted Wang, Ph.D., of Puissance Capital Management, to Board of Directors Apr 9, 2018 08:00AM
Form SC 13D/A Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P. Apr 3, 2018 05:12PM
TRACON Pharmaceutical (TCON) Announces $38.7 Million Private Placement of Common Stock and Warrants Mar 23, 2018 08:32AM
TRACON Pharmaceuticals Announces $38.7 Million Private Placement Mar 23, 2018 08:30AM


Dec 8, 2016 11:26AM Form SC 13D/A Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P.
Nov 29, 2016 05:49PM Form 4 Tracon Pharmaceuticals, For: Nov 29 Filed by: New Enterprise Associates 14, L.P.
Mar 10, 2015 04:15PM TRACON Pharmaceuticals Reports 2014 Year-End Financial Results and Recent Corporate Highlights
Mar 10, 2015 04:15PM TRACON Pharmaceuticals Reports 2014 Year-End Financial Results and Recent Corporate Highlights
Feb 11, 2015 03:34PM Form SC 13D Tracon Pharmaceuticals, Filed by: New Enterprise Associates 14, L.P.
Feb 5, 2015 03:55PM Form 4 Tracon Pharmaceuticals, For: Feb 04 Filed by: New Enterprise Associates 14, L.P.
Jan 30, 2015 08:09AM TRACON Pharmaceuticals (TCON) Prices 3.6M Common IPO at $10/Share
Jan 29, 2015 09:34PM TRACON Pharmaceuticals Announces Pricing of Initial Public Offering